write short 1 paragraph summary for each article 6 hours
EDITORIAL
Correspondence:
Ewa Rajpert-De Meyts
E-mail: [email protected]
doi: 10.1111/andr.12243
Special issue on endocrine disruption and reproductive health
1 E. Rajpert-De Meyts and
2 D. T. Carrell
1Department of Growth and Reproduction, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark, and 2Departments of Surgery (Urology), Obstetrics and Gynecology, and Human Genetics, University of Utah School of Medicine, Salt Lake City, UT, USA
It is our pleasure to introduce to our readers a special thematic
issue of Andrology. This is the third of such publications, follow-
ing one special issue focused on genetic aspects of male infertil-
ity (Krausz & Carell, 2014) and another comprising papers on
basic and clinical aspects of testicular germ cell cancer (Rajpert-
De Meyts et al., 2015).
The current issue is devoted to the timely topic of endocrine
disruption and the role of this mechanism in the pathogenesis of
increasingly widespread reproductive disorders. This is a very
important issue that remains to be hotly debated in scientific
and political circles due to conflicting interests from chemical
and pharmacological industry, agriculture, governmental com-
mittees as well as NGOs and consumer organizations. On the
one hand, many compounds have immensely contributed to
protecting our health (e.g. from pests) and facilitating daily life.
On the other hand, some of the commonly used chemicals
turned out to have unexpected negative effects on other aspects
of our health, with the endocrine system particularly vulnerable.
The debate has been additionally fueled by conflicting data from
research labs working on different species and often using doses
not reflecting the real exposure. Despite these controversies, the
field has been expanding because of the constant stream of
newly identified endocrine disrupters and novel pathways they
affect. The current status of the field is nicely summarized in the
editorial opening this issue (Andersson et al., 2016).
The content of this special issue highlights some of the perti-
nent topics in the field of endocrine disruption that are of rele-
vance to andrologists and researchers interested in male
reproduction. However, the issue also contains a few articles that
deal with female reproduction and neuroendocrinology. Most of
the articles are based on lectures presented at the 8th
Copenhagen Workshop on Endocrine Disrupters, held in May
2015. These meetings have grown to be the preeminent gather-
ing of leading experts in the field that sets a tone for research in
the field.
We are proud that Andrology participates in the dissemination
of data presented at this and other ‘cutting-edge’ meetings. We
have also added a handful of thematically matching papers sub-
mitted to Andrology independently of the meeting. All papers in
this special issue underwent a usual stringent review process
according to the journal’s standard. The issue has been edited by
a guest associate editor, Anna-Maria Andersson, the main orga-
nizer of the Copenhagen meeting, and the director of the Danish
Center for Endocrine Disrupters (www.cend.dk), founded by the
Danish Ministry of Environment, which also supported the
meeting financially. She was helped by members of the Pro-
gramme Committee, Katrine Bay, Hanne Frederiksen, and Niels
E. Skakkebæk, as well as Kenneth Grigor, who edited the meeting
comments included in some of the papers. We are grateful for
their contribution, and hope that our readers will find the issue
interesting.
REFERENCES Andersson AM, Bay K, Frederiksen H & Skakkebaek NE. (2016) Endocrine
disrupters: we need research, biomonitoring, and action. Andrology 4,
556–560.
Krausz C & Carell DT. (2014) Advances in understanding the genetics
underlying male infertility and evolving diagnostic and treatment
options. Andrology 2, 302–303.
Rajpert-De Meyts E, Daugaard G, Almstrup K, Jørgensen A, Rørth M,
Jørgensen N, von der Maase H & Skakkebaek NE. (2015) Increasing
international efforts to understand and conquer testicular germ cell
cancer. Andrology 3, 1–3.
© 2016 American Society of Andrology and European Academy of Andrology Andrology, 2016, 4, 555 555
ISSN: 2047-2919 ANDROLOGY
Copyright of Andrology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.